Leap Investments »

Cue Biopharma shares owned by Leap Investments

Quarter-by-quarter ownership of Cue Biopharma (CUE) shares owned by Leap Investments from 13F filings

Historical chart of Leap Investments investment in Cue Biopharma

Tip: Access up to 7 years of quarterly data

All positions including Cue Biopharma held by Leap Investments consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cue Biopharma by Leap Investments

Quarter filed Position value Share count Share price at filing
2020-06-30 $304k 12k 24.52
2019-12-31 $241k 15k 15.88

More positions owned by Leap Investments

Penn National Gaming Common Stock (PENN)
Crowdstrike Holdings Common Stock (CRWD)
Domino's Pizza Common Stock (DPZ)
Phillips 66 Common Stock (PSX)
Seattle Genetics Common Stock
Discover Financial Services Common Stock (DFS)
Uber Technologies Common Stock (UBER)
Advanced Micro Devices Common Stock (AMD)
Annaly Capital Management Reit
Coca-Cola Co/The Common Stock (KO)
Taiwan Semiconductor Manufacturing Depositary Receipt (TSM)
Western Digital Corp Common Stock (WDC)
Raytheon Technologies Corp Common Stock (RTX)
Ford Motor Common Stock (F)
DexCom Common Stock (DXCM)

View all positions for Leap Investments

Top funds holding Cue Biopharma

Vanguard Group
BlackRock
Bleichroeder
Geode Capital Management
Robertson Stephens Wealth Management
Dimensional Fund Advisors
Northern Trust
Millennium Management
Monaco Asset Management SAM
Sigma Planning
Bank of America Corporation
GSA Capital Partners
Stifel Financial
Citadel Advisors
Morgan Stanley

View all funds holding Cue Biopharma